Anti-TNF Therapy for Refractory Colitis in Hospitalized Children

CompletedOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

February 11, 2019

Study Completion Date

November 30, 2019

Conditions
Colitis, UlcerativeBowel Diseases, Inflammatory
Interventions
DRUG

Infliximab

No standard dosing regimen will be used and the dose of infliximab will be determined by the treating physician

Trial Locations (7)

19104

Children's Hospital of Philadelphia, Philadelphia

30322

Emory University School of Medicine, Atlanta

43205

Nationwide Children's Hospital, Columbus

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

06016

Connecticut Children's Hospital Medical Center, Hartford

02903

Rhode Island Hospital, Providence

Unknown

The Hospital for Sick Children, Toronto

All Listed Sponsors
collaborator

Crohn's and Colitis Foundation

OTHER

lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT02799615 - Anti-TNF Therapy for Refractory Colitis in Hospitalized Children | Biotech Hunter | Biotech Hunter